Association of gut microbiota and metabolites with tumor response to immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma.

被引：5
|
作者：
Lee, Pei-Chang
Wu, Chi-Jung
Hung, Ya-Wen
Lee, Chieh-Ju
Chao, Yee
Hou, Ming-Chih
Kuo, Yu-Lun
Chou, Shih-Hsuan
Huang, Yi-Hsiang
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Taipei, Taiwan
[4] Biotools Co Ltd, New Taipei, Taiwan
[5] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Inst Clin Med, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16165
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma
    Li, Rong
    Li, Wenli
    Yang, Qing
    Guan, Yujuan
    Chen, Yongru
    Zhu, Peilin
    Su, Kaiyan
    Li, Qi
    Hu, Xiaoyun
    Zang, Mengya
    Zhao, Miaoxian
    Zhong, Manhua
    Yan, Jingquan
    Yang, Keli
    Zhu, Wei
    Lin, Zhanzhou
    Yuan, Guosheng
    Chen, Jinzhang
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [42] Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
    Akbulut, Zeynep
    Aru, Basak
    Aydin, Furkan
    Demirel, Gulderen Yanikkaya
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
    van Doorn, Diederick J.
    Takkenberg, Robert Bart
    Klumpen, Heinz-Josef
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 23
  • [44] Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A review
    Sun, Liwei
    Xu, Xuelong
    Meng, Fanguang
    Liu, Qian
    Wang, Hankang
    Li, Xiaodong
    Li, Guijie
    Chen, Feng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma A Meta-analysis
    Jacome, Alexandre A.
    Castro, Ana Carolina G.
    Vasconcelos, Joao Paulo S.
    Silva, Maria Helena C. R.
    Lessa, Marco Antonio O.
    Moraes, Eduardo D.
    Andrade, Aline C.
    Lima, Frederico M. T.
    Farias, Joao Paulo F.
    Gil, Roberto A.
    Prolla, Gabriel
    Garicochea, Bernardo
    JAMA NETWORK OPEN, 2021, 4 (12) : E2136128
  • [46] Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma
    Akula, Vinita
    Chen, Lily
    Acikgoz, Yusuf
    Klein, Katherine
    Yavuz, Betul Gok
    Cevik, Lokman
    Demir, Tarik
    Manne, Ashish
    Sahin, Ilyas
    Kaseb, Ahmed
    Hasanov, Elshad
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [47] Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
    Xu, Ying
    Wang, Zheng
    Li, Fufeng
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [48] Immune checkpoint inhibitors and tumor mutation burden as predictive biomarkers in hepatocellular carcinoma
    Shrestha, R.
    Prithviraj, P.
    Bridle, K. R.
    Crawford, D. H. G.
    Anaka, M.
    Jayachandran, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 31 - 31
  • [49] Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?
    Delaye, Matthieu
    Rousseau, Adrien
    Mailly-Giacchetti, Leah
    Assoun, Sandra
    Sokol, Harry
    Neuzillet, Cindy
    PHARMACOLOGY & THERAPEUTICS, 2023, 247
  • [50] Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma
    Hu, Yue
    Pan, Tao
    Cai, Xi
    He, Quan-Sheng
    Zheng, Yu-Bao
    Huang, Ming-Sheng
    Jiang, Zai-Bo
    Chen, Jun-Wei
    Wu, Chun
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (04) : 1837 - +
12345